Guizhou Xinbang Pharmaceutical マネジメント
マネジメント 基準チェック /34
Guizhou Xinbang Pharmaceutical's CEO is Lingzhong Kong, appointed in Aug 2016, has a tenure of 8.25 years. directly owns 0.04% of the company’s shares, worth CN¥2.68M. The average tenure of the management team and the board of directors is 9.5 years and 0.8 years respectively.
主要情報
Lingzhong Kong
最高経営責任者
CN¥791.7k
報酬総額
CEO給与比率 | n/a |
CEO在任期間 | 8.3yrs |
CEOの所有権 | 0.04% |
経営陣の平均在職期間 | 9.5yrs |
取締役会の平均在任期間 | less than a year |
経営陣の近況
Recent updates
CEO(最高経営責任者
Lingzhong Kong (56 yo)
8.3yrs
在職期間
CN¥791,700
報酬
Ms. Lingzhong Kong serves as General Manager of Guizhou Xinbang Pharmaceutical Co., Ltd. since August 05, 2016 and served as its Secretary of the Board and Executive Deputy General Manager. Ms. Kong has be...
リーダーシップ・チーム
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
GM & Director | 8.3yrs | CN¥791.70k | 0.040% CN¥ 2.7m | |
CFO & Deputy GM | 9.5yrs | CN¥491.70k | 0.0045% CN¥ 302.8k | |
Deputy General Manager | no data | CN¥491.70k | 0.00046% CN¥ 30.9k | |
Deputy GM & Secretary of the Board | 10.7yrs | CN¥491.70k | 0.00038% CN¥ 25.5k | |
Deputy General Manager | no data | CN¥551.60k | 0.0075% CN¥ 502.2k | |
Accounting Supervisor | no data | データなし | データなし |
9.5yrs
平均在職期間
55yo
平均年齢
経験豊富な経営陣: 002390's management team is seasoned and experienced (9.5 years average tenure).
取締役
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
GM & Director | 10.5yrs | CN¥791.70k | 0.040% CN¥ 2.7m | |
Independent Director | less than a year | データなし | データなし | |
Shareholder Supervisor | 7yrs | データなし | 0.0050% CN¥ 337.0k | |
Chairman | 2.5yrs | CN¥791.70k | 1.06% CN¥ 71.2m | |
Non-Independent Director | less than a year | データなし | 0.0079% CN¥ 529.0k | |
Independent Director | 1.5yrs | CN¥40.00k | データなし | |
Supervisor | less than a year | データなし | 0.00080% CN¥ 53.7k | |
Non-Independent Director | less than a year | データなし | データなし | |
Non-Independent Director | less than a year | データなし | データなし |
0.8yrs
平均在職期間
39yo
平均年齢
経験豊富なボード: 002390's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.